Interim monitoring of efficacy data is important and appropriate
J Clin Epidemiol
.
2008 Mar;61(3):203-4.
doi: 10.1016/j.jclinepi.2007.08.002.
Authors
Matthew R Sydes
1
,
Mahesh K B Parmar
Affiliation
1
MRC Clinical Trials Unit, Cancer Group, 222 Euston Road, London NWI 2DA, UK. matthew.sydes@ctu.mrc.ac.uk
PMID:
18226741
DOI:
10.1016/j.jclinepi.2007.08.002
No abstract available
Publication types
Comment
MeSH terms
Clinical Trials Data Monitoring Committees*
Humans
Randomized Controlled Trials as Topic*
Treatment Outcome